Nitric oxide-induced p53 accumulation and regulation of inducible nitric oxide synthase expression by wild-type p53

被引:385
作者
Forrester, K
Ambs, S
Lupold, SE
Kapust, RB
Spillare, EA
Weinberg, WC
FelleyBosco, E
Wang, XW
Geller, DA
Tzeng, E
Billiar, TR
Harris, CC
机构
[1] NCI, HUMAN CARCINOGENESIS LAB, NATL INST HLTH, BETHESDA, MD 20892 USA
[2] NCI, CELLULAR CARCINOGENESIS & TUMOR PROMOT LAB, NATL INST HLTH, BETHESDA, MD 20892 USA
[3] INST PHARMACOL & TOXICOL, CH-1007 LAUSANNE, SWITZERLAND
[4] UNIV PITTSBURGH, DEPT SURG, PITTSBURGH, PA 15261 USA
关键词
tumor suppressor gene; mutagenesis; carcinogenesis;
D O I
10.1073/pnas.93.6.2442
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The tumor suppressor gene product p53 plays an important role in the cellular response to DNA damage from exogenous chemical and physical mutagens. Therefore, we hypothesized that p53 performs a similar role in response to putative endogenous mutagens, such as nitric oxide (NO). We report here that exposure of human cells to NO generated from an NO donor or from overexpression of inducible nitric oxide synthase (NOS2) results in p53 protein accumulation, In addition, expression of wild-type (WT) p53 in a variety of human tumor cell lines, as well as murine fibroblasts, results in down-regulation of NOS2 expression through inhibition of the NOS2 promoter, These data are consistent with the hypothesis of a negative feedback loop in which endogenous NO-induced DNA damage results in WT p53 accumulation and provides a novel mechanism by which p53 safeguards against DNA damage through p53-mediated transrepression of NOS2 gene expression, thus reducing the potential for NO-induced DNA damage.
引用
收藏
页码:2442 / 2447
页数:6
相关论文
共 59 条
[1]   REGULATION OF THE HUMAN HSP70 PROMOTER BY P53 [J].
AGOFF, SN ;
HOU, J ;
LINZER, DIH ;
WU, B .
SCIENCE, 1993, 259 (5091) :84-87
[2]   THE CAUSES AND PREVENTION OF CANCER [J].
AMES, BN ;
GOLD, LS ;
WILLETT, WC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (12) :5258-5265
[3]   MUTAGENICITY OF NITRIC-OXIDE AND ITS INHIBITION BY ANTIOXIDANTS [J].
ARROYO, PL ;
HATCHPIGOTT, V ;
MOWER, HF ;
COONEY, RV .
MUTATION RESEARCH, 1992, 281 (03) :193-202
[4]   SUPPRESSION OF HUMAN COLORECTAL-CARCINOMA CELL-GROWTH BY WILD-TYPE-P53 [J].
BAKER, SJ ;
MARKOWITZ, S ;
FEARON, ER ;
WILLSON, JKV ;
VOGELSTEIN, B .
SCIENCE, 1990, 249 (4971) :912-915
[5]  
BECKMAN JS, 1994, PROG BRAIN RES, V103, P371
[6]   NITRIC-OXIDE SYNTHASE ACTIVITY IN ULCERATIVE-COLITIS AND CROHNS-DISEASE [J].
BOUGHTONSMITH, NK ;
EVANS, SM ;
HAWKEY, CJ ;
COLE, AT ;
BALSITIS, M ;
WHITTLE, BJR ;
MONCADA, S .
LANCET, 1993, 342 (8867) :338-340
[7]  
CHARTRAIN NA, 1994, J BIOL CHEM, V269, P6765
[8]   STRUCTURAL DIVERSITY IN THE 5'-UNTRANSLATED REGION OF CYTOKINE-STIMULATED HUMAN INDUCIBLE NITRIC-OXIDE SYNTHASE MESSENGER-RNA [J].
CHU, SC ;
WU, HP ;
BANKS, TC ;
EISSA, NT ;
MOSS, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (18) :10625-10630
[9]   THYMOCYTE APOPTOSIS INDUCED BY P53-DEPENDENT AND INDEPENDENT PATHWAYS [J].
CLARKE, AR ;
PURDIE, CA ;
HARRISON, DJ ;
MORRIS, RG ;
BIRD, CC ;
HOOPER, ML ;
WYLLIE, AH .
NATURE, 1993, 362 (6423) :849-852
[10]  
COBBS CS, 1995, CANCER RES, V55, P727